Effect of Single Doses of YF476 on Stomach Acidity Compared With Ranitidine and Placebo in Fasted and Fed States
Phase 1
Completed
- Conditions
- First Posted Date
- 2012-02-24
- Last Posted Date
- 2012-02-24
- Lead Sponsor
- Trio Medicines Ltd.
- Target Recruit Count
- 22
- Registration Number
- NCT01538797
- Locations
- π¬π§
Hammersmith Medicines Research, London, United Kingdom
YF476 and Type I Gastric Carcinoids (Norway)
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2011-09-30
- Last Posted Date
- 2015-05-15
- Lead Sponsor
- Trio Medicines Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT01444014
- Locations
- π³π΄
Institutt for kreftforskning og molekylaer medisin, Trondheim, Norway
YF476 and Type I Gastric Carcinoids
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-04-20
- Last Posted Date
- 2019-08-19
- Lead Sponsor
- Trio Medicines Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT01339169
- Locations
- π¬π§
Royal Liverpool University Hospital, Liverpool, United Kingdom
Β© Copyright 2024. All Rights Reserved by MedPath